Health System

The FDA issued a safety alert about efficacy and potential safety concerns with a combination therapy being studied for the treatment of breast cancer.

Oncology pharmacists have implemented new ways to communicate with patients, schedule visits and treatments, and re-evaluate their medications regimens during the pandemic.

Here's the coronavirus-related news from this week that you should know.

ASHP issued its recommended principles for the development, distribution, allocation, and oversight of an eventual COVID-19 vaccine.

The removal of the boxed warning from canagliflozin was based on the FDA’s review of new data from 3 clinical trials.

Amisuplride injection (Barhemsys; Acacia) is the first and only antiemetic to be approved for the rescue treatment of PONV in patients who have failed prior prophylaxis with an agent of a different class.

An examination of how telehealth services for medically underserved patients in rural areas improve access to pharmacists for chronic care management.

Here's this week's coronavirus-related news that you should know.

Results of the study demonstrated conclusive evidence of drug dose gender gaps from 86 different FDA-approved medications.

Two senior administration officials from Operation Warp Speed offered the latest updates on COVID-19 vaccine development.

Here's the coronavirus-related news from this week that you should know.

The COVID-19 crisis poses unique challenges for managing controlled substances in hospitals.

The opioid’s indication was based on several randomized controlled trials, where patients reported decreased pain.

Here's this week's coronavirus-related news you should know.

The grants are part of the administration’s continuing focus on rural health initiatives.

ESMO released changes to its recommendations on how to manage patients with cancer during the COVID-19 pandemic.

The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.

The state joins New York and Minnesota in providing COVID-19 vaccination access through pharmacy.

A panel has given a “weak recommendation” for the use of remdesivir in patients with severe coronavirus disease 2019.

Our first episode of our latest Cannabis Series is focused on the burgeoning medical marijuana landscape, featuring FDA's guidelines and research on the diverse benefits of cannabis as medicine.

Joshua Miller, MD MPH and medical director of diabetes care for Stony Brook Medicine, discusses continuous glucose monitoring (CGM) technology, which the FDA has authorized for use in hospitals amid the COVID-19 pandemic.

Here's this week's coronavirus-related news.

The American Society of Health-System Pharmacists (ASHP) announced plans to hold the 2020 Midyear Clinical Meeting in December as an all-virtual experience.

NACDS, APhA, NCPA, and others warn that overlooking DIR fee reform will be detrimental to pharmacy viability.

Experts will examine the prospects of several COVID-19 vaccine candidates that are entering phase 3 trials.